In this insightful video interview, we sit down with Marty Henehan, Vice President of Business Development – Head of North America from Mabion to discuss key trends shaping the biopharma industry and the Biosecure Act. Additionally, the interview highlights the strategic advantages of manufacturing in Europe. Join us as we uncover the future of biopharma and the critical choices that companies face in a rapidly evolving landscape.
TWENTYFOURSEVENBIOPHARMA